Skip to main content
ANIK filings

Corporate insider profile

Stephen D. Griffin Filing Activity

Latest reported as President and CEO of Anika Therapeutics, Inc. (ANIK).

Purchase filings
1
Reported companies
1
Net open-market value
$149,881
Latest transaction
Apr 30, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Apr 30, 2026Anika Therapeutics, Inc. (ANIK)President and CEOOpen Market Purchase12,200$12.29$149,881